Literature DB >> 24646649

Combination therapy adding tadalafil to existing ambrisentan in patients with pulmonary arterial hypertension.

Akihiro Hirashiki1, Takahisa Kondo1, Toyoaki Murohara2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24646649     DOI： 10.1038/hr.2014.37

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  3 in total

1.  Treatment for pulmonary hypertension due to left heart diseases.

Authors:  Kazufumi Nakamura
Journal:  Hypertens Res       Date:  2015-11-05       Impact factor: 3.872

2.  Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension.

Authors:  Rong Jiang; Zi-Sheng Ai; Xin Jiang; Ping Yuan; Dong Liu; Qin-Hua Zhao; Jing He; Lan Wang; Mardi Gomberg-Maitland; Zhi-Cheng Jing
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

3.  The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases.

Authors:  Ghazwan Butrous
Journal:  Glob Cardiol Sci Pract       Date:  2014-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.